Back to search results
Completed

Mild Cognitive Impairment, Mild Alzheimer's

A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease

LMDD | {{ defaultRegistry.registryAnchorText }} NCT03019536 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

This study involves repeated doses of LY3303560 given by injection for 25 weeks. The study will examine how safe repeated doses of LY3303560 are, whether they cause side effects in participants with mild cognitive impairment or Alzheimer's Disease, and how LY3303560 is handled by the body and acts in the body.

Completed Study

The results of this study are not yet available.

Time Commitment

participation could last up to 18.5 months and include up to 27 visits to the study center.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

50+ years
  • Participants must have Mild Cognitive Impairment (MCI) due to Alzheimer's Disease (AD) or mild-to-moderate AD
  • Female participants must not be of child-bearing potential
  • Participants must have a body weight of at least 50 kilogram (kg) or 110 pounds (lb)
  • Participants must be able to undergo Magnetic Resonance Imaging (MRI)
  • Participants must be willing to undergo a lumbar puncture (spinal tap)

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.